Cleared Traditional

EMPRINT PROCEDURE PLANNING APPLICATION (K142048) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2014
Decision
51d
Days
Class 2
Risk

K142048 is an FDA 510(k) clearance for the EMPRINT PROCEDURE PLANNING APPLICATION. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Covidien, LLC (Mansfield, US). The FDA issued a Cleared decision on September 17, 2014 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Covidien, LLC devices

Submission Details

510(k) Number K142048 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 2014
Decision Date September 17, 2014
Days to Decision 51 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 107d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 730
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K142048.
syngo.via MI Workflows
K151192 · Siemens Medical Solutions USA, Inc. · Jun 2015
Scenium
K150192 · Siemens Medical Solutions USA, Inc. · Mar 2015
eSie Apps Suite
K143254 · Siemens Medical Solutions USA, Inc. · Dec 2014
SYNGO.MR NEUROLOGY, SYNGO.MMR GENERAL
K140897 · Siemens Medical Solutions USA, Inc. · Jul 2014
ESIE APPS SUITE
K141554 · Siemens Medical Solutions USA, Inc. · Jul 2014
SYNO MR NEUROLOGY, SYNGO MR ONCOLOGY, SYNGO. MR BREVIS, SYNGO MMR GENERAL
K133401 · Siemens Medical Solutions USA, Inc. · Mar 2014